Should You Buy Qiagen NV (QGEN) Stock on Tuesday?

The market has been high on Qiagen NV (QGEN) stock recently. QGEN gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Qiagen NV has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on QGEN!

See Full QGEN Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With QGEN Stock Today?

Qiagen NV (QGEN) stock is trading at $40.83 as of 1:31 PM on Tuesday, Nov 28, a gain of $0.22, or 0.54% from the previous closing price of $40.61. The stock has traded between $40.43 and $40.85 so far today. Volume today is low. So far 413,948 shares have traded compared to average volume of 1,360,520 shares.

More About Qiagen NV

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%). Click Here to get the full Stock Report for Qiagen NV stock.